Male bladder cancer vulnerability could lead to a new treatment approach
Turkey unveils deal for 50 mn Sputnik V doses
28 April 2021Algorithm scours electronic health records to reveal hidden kidney disease
28 April 2021Male bladder cancer vulnerability could lead to a new treatment approach
A protein variant common in malignant bladder tumor cells may serve as a new avenue for treating bladder cancer. A multi-institution study led by UC Davis Comprehensive Cancer Center researchers found that targeting androgen receptors—a type of protein that is crucial for the function of testosterone—may destroy cancer cells.
